NEG+ Innovations, Inc.
Physician-Scientist.
Inventor & Co-Investor. Women's Health Executive.
Dr. Jimmy Belotte is a board-certified OB/GYN, physician-scientist, and inventor whose work sits at the intersection of women's health surgical innovation, translational medicine, and medical device entrepreneurship. As Medical Director, Oncology Clinical Development at GlaxoSmithKline, he leads regulatory strategy and protocol design across Phase I/II gynecologic oncology programs — directly informing NEG+'s clinical development and regulatory approach within the broader women's health landscape.
Dr. Belotte's academic foundation — including a PhD in Reproductive Physiology and an MBA with concentrations in healthcare and finance — positions him at the intersection of clinical rigor, translational science, and venture-grade business execution. As both inventor and co-investor in NEG+ Innovations, he brings the rare combination of hands-on surgical insight and capital commitment that defines founder-led medtech. As Former Clinical Associate Professor at Albert Einstein College of Medicine, he maintains active academic clinical relationships that serve as the backbone of NEG+'s investigator network and NIH STTR academic partnership strategy.
NEG+ Innovations was built from a clinical problem-first perspective: each device in the portfolio emerged directly from documented deficiencies Dr. Belotte encountered in women's health surgical practice — then validated through voice-of-customer research, engineering feasibility, and market analysis before a single patent was filed. Every invention carries both his intellectual and financial conviction.
